For help on how to get the results you want, see our search tips.
1510 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Libtayo (updated)
Cemiplimab, Carcinoma, Squamous Cell
Date of authorisation: 28/06/2019,
, 
, Revision: 2, Authorised, Last updated: 21/07/2020
-
List item
Human medicine European public assessment report (EPAR): Lenvima (updated)
lenvatinib mesylate, Thyroid Neoplasms
Date of authorisation: 28/05/2015,, 
, Revision: 12, Authorised, Last updated: 21/07/2020
-
List item
Human medicine European public assessment report (EPAR): Otezla (updated)
apremilast, Arthritis, Psoriatic, Psoriasis
Date of authorisation: 15/01/2015, Revision: 14, Authorised, Last updated: 21/07/2020 -
List item
Human medicine European public assessment report (EPAR): Wakix (updated)
pitolisant, Narcolepsy
Date of authorisation: 31/03/2016,, 
, Revision: 8, Authorised, Last updated: 21/07/2020
-
List item
Human medicine European public assessment report (EPAR): Lemtrada (updated)
alemtuzumab, Multiple Sclerosis
Date of authorisation: 12/09/2013,
, , Revision: 10, Authorised, Last updated: 21/07/2020
-
List item
Human medicine European public assessment report (EPAR): Dafiro (updated)
amlodipine, valsartan, Hypertension
Date of authorisation: 15/01/2007, Revision: 26, Authorised, Last updated: 21/07/2020 -
List item
Human medicine European public assessment report (EPAR): Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.) (updated)
beclometasone dipropionate anhydrous, formoterol fumarate dihydrate, glycopyrronium, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 23/04/2018, Revision: 2, Authorised, Last updated: 21/07/2020 -
List item
Human medicine European public assessment report (EPAR): Pioglitazone Teva Pharma (updated)
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 26/03/2012,
, Revision: 11, Authorised, Last updated: 21/07/2020
-
List item
Human medicine European public assessment report (EPAR): Voncento (updated)
Human coagulation factor VIII, human von willebrand factor, Hemophilia A, von Willebrand Diseases
Date of authorisation: 12/08/2013, Revision: 14, Authorised, Last updated: 21/07/2020 -
List item
Human medicine European public assessment report (EPAR): Dexmedetomidine Accord (updated)
dexmedetomidine, Premedication
Date of authorisation: 13/02/2020,, Revision: 1, Authorised, Last updated: 21/07/2020
-
List item
Human medicine European public assessment report (EPAR): Trydonis (updated)
Beclometasone dipropionate, formoterol fumarate dihydrate, glycopyrronium, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 26/04/2018, Revision: 2, Authorised, Last updated: 21/07/2020 -
List item
Human medicine European public assessment report (EPAR): Brintellix (updated)
Vortioxetine, Depressive Disorder, Major
Date of authorisation: 18/12/2013, Revision: 15, Authorised, Last updated: 21/07/2020 -
List item
Human medicine European public assessment report (EPAR): Copalia HCT (updated)
amlodipine, valsartan, hydrochlorothiazide, Hypertension
Date of authorisation: 03/11/2009, Revision: 16, Authorised, Last updated: 21/07/2020 -
List item
Human medicine European public assessment report (EPAR): Exjade (updated)
deferasirox, beta-Thalassemia, Iron Overload
Date of authorisation: 28/08/2006,, Revision: 45, Authorised, Last updated: 20/07/2020
-
List item
Human medicine European public assessment report (EPAR): Pregabalin Accord (updated)
pregabalin, Anxiety Disorders, Epilepsy
Date of authorisation: 28/08/2015,, Revision: 8, Authorised, Last updated: 20/07/2020
-
List item
Human medicine European public assessment report (EPAR): Pegasys (updated)
peginterferon alfa-2a, Hepatitis C, Chronic, Hepatitis B, Chronic
Date of authorisation: 20/06/2002, Revision: 38, Authorised, Last updated: 20/07/2020 -
List item
Human medicine European public assessment report (EPAR): Glidipion (previously Pioglitazone Actavis Group) (updated)
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 15/03/2012,, Revision: 7, Authorised, Last updated: 20/07/2020
-
List item
Human medicine European public assessment report (EPAR): Carmustine Obvius (updated)
carmustine, Hodgkin Disease, Lymphoma, Non-Hodgkin
Date of authorisation: 18/07/2018,, Revision: 4, Authorised, Last updated: 16/07/2020
-
List item
Human medicine European public assessment report (EPAR): Fulphila (updated)
pegfilgrastim, Neutropenia
Date of authorisation: 20/11/2018,, 
, Revision: 4, Authorised, Last updated: 16/07/2020
-
List item
Human medicine European public assessment report (EPAR): Zonegran (updated)
zonisamide, Epilepsies, Partial
Date of authorisation: 10/03/2005, Revision: 31, Authorised, Last updated: 16/07/2020 -
List item
Human medicine European public assessment report (EPAR): Hetlioz (updated)
tasimelteon, Sleep Disorders, Circadian Rhythm
Date of authorisation: 03/07/2015,, Revision: 5, Authorised, Last updated: 16/07/2020
-
List item
Human medicine European public assessment report (EPAR): Temozolomide Accord (updated)
temozolomide, Glioma, Glioblastoma
Date of authorisation: 15/03/2010,, Revision: 19, Authorised, Last updated: 15/07/2020
-
List item
Human medicine European public assessment report (EPAR): Fycompa (updated)
perampanel, Epilepsies, Partial
Date of authorisation: 23/07/2012, Revision: 18, Authorised, Last updated: 15/07/2020 -
List item
Human medicine European public assessment report (EPAR): Ultomiris (updated)
ravulizumab, Hemoglobinuria, Paroxysmal
Date of authorisation: 02/07/2019,, Revision: 3, Authorised, Last updated: 15/07/2020
-
List item
Human medicine European public assessment report (EPAR): Kolbam (updated)
cholic acid, Metabolism, Inborn Errors
Date of authorisation: 20/11/2015,
, Revision: 14, Withdrawn, Last updated: 15/07/2020